Page last updated: 2024-10-31

mitoxantrone and Nervous System Disorders

mitoxantrone has been researched along with Nervous System Disorders in 3 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Because autoimmune neurologic disorders are so diverse, evidence from randomized controlled trials is limited for most of the immunotherapies used in neurology."2.48Immunotherapies in neurologic disorders. ( Graves, D; Vernino, S, 2012)
"To date, all available therapies for prostate cancer are plagued by adverse effects."2.41Complications of chemotherapy for prostate cancer. ( Beer, TM; Bubalo, JS, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graves, D1
Vernino, S1
Beer, TM1
Bubalo, JS1
Hall, C1
Dougherty, WJ1
Lebish, IJ1
Brock, PG1
Man, A1

Reviews

2 reviews available for mitoxantrone and Nervous System Disorders

ArticleYear
Immunotherapies in neurologic disorders.
    The Medical clinics of North America, 2012, Volume: 96, Issue:3

    Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antibodies, Mono

2012
Complications of chemotherapy for prostate cancer.
    Seminars in urologic oncology, 2001, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Docetaxel; Ga

2001

Other Studies

1 other study available for mitoxantrone and Nervous System Disorders

ArticleYear
Warning against use of intrathecal mitoxantrone.
    Lancet (London, England), 1989, Apr-01, Volume: 1, Issue:8640

    Topics: Animals; Haplorhini; Humans; Injections, Spinal; Mitoxantrone; Nervous System Diseases

1989